{"id":896669,"date":[{"year":1993,"month":1,"day":28}],"page":"6","source":"","region":"","masthead":"养生","special_issue":"养生","column":"寻医问药","genre":"","count":"224","ytitle":"","mtitle":"慢性肝炎专家门诊","ftitle":"","authors":["瞿瑶"],"text":[{"type":"paragraph","text":"空军广州医院研制的促肝细胞生长素(HGF)，是我国实施新药审批法以来首次获批的一类生化新药。经全国重症肝炎攻关组验证，该药可使重症肝炎的病死率由原先的百分之五十四点五降低到百分之三十六点六。近年临床发现，该药用于慢性活动型肝炎，其降低转氨酶及退黄疸功能均比一般常用药快。目前，上海慢性肝炎防治中心受空军广州医院委托，在本市作进一步临床及机理研究，第二军医大学附属长征医院肝炎门诊每周一、四上午设专家咨询门诊。"},{"type":"paragraph","text":"(瞿瑶)"}]}